# Abbott

> Abbott is a diversified health-technology company that sells consumer nutrition, continuous glucose monitors, diagnostic systems, cardiovascular devices and branded generic medicines. Founded in Chicago in 1888, it now reaches more than 2 billion people in over 160 countries, pairing mass-market brands such as Ensure and Similac with hospital platforms, implanted devices and a growing cancer-diagnostics portfolio.

- **Founded:** 1888
- **Headquarters:** Abbott Park, Illinois, United States
- **Founders:** Wallace Calvin Abbott (Founder, physician and pharmacist)
- **Team size:** Approximately 122,000 employees worldwide
- **Products:** FreeStyle Libre, Lingo, Alinity, MitraClip, CardioMEMS
- **Notable:** Grew from a Chicago pharmacy founded in 1888 into a healthcare company serving more than 2 billion people in over 160 countries., FreeStyle Libre became a widely used continuous glucose monitoring platform, with roughly 6 million users reported in 2024., MitraClip has treated more than 200,000 people across more than 75 countries.

## Products & services

- **FreeStyle Libre** — A family of continuous glucose monitoring systems that turns interstitial glucose readings into real-time trends for diabetes management.
- **Lingo** — An over-the-counter consumer biowearable and app designed to help adults understand glucose responses and build healthier habits.
- **Alinity** — A harmonized family of laboratory, blood-screening, molecular and point-of-care diagnostic systems built to simplify testing workflows.
- **MitraClip** — A catheter-delivered device that repairs selected leaking mitral valves without open-heart surgery.
- **CardioMEMS** — An implantable pulmonary artery pressure sensor used for remote monitoring of selected heart-failure patients.
- **AVEIR DR** — A dual-chamber leadless pacemaker system designed to coordinate pacing without conventional transvenous leads.
- **Ensure, Similac, PediaSure and Glucerna** — Consumer and clinical nutrition brands spanning adults, infants, children and people managing diabetes.
- **Cancer diagnostics** — A portfolio added through Exact Sciences that includes Cologuard, Oncotype DX, Oncodetect and Cancerguard.
- **Established pharmaceutical products** — Branded generic medicines marketed primarily in emerging markets across therapeutic areas.

## Achievements

- Grew from a Chicago pharmacy founded in 1888 into a healthcare company serving more than 2 billion people in over 160 countries.
- FreeStyle Libre became a widely used continuous glucose monitoring platform, with roughly 6 million users reported in 2024.
- MitraClip has treated more than 200,000 people across more than 75 countries.
- AVEIR DR became the first FDA-approved dual-chamber leadless pacing system in 2023.
- Reported $44.3 billion in 2025 revenue and invested $2.9 billion in research and development.
- Completed the Exact Sciences acquisition in March 2026, creating a major cancer-screening and precision-oncology platform.
- Maintained more than a century of uninterrupted quarterly dividends and over five decades of annual dividend increases.

## Latest updates

- **2026-07** — Reported second-quarter sales growth of 13.0% and raised full-year adjusted EPS guidance to $5.45-$5.60 while retaining comparable sales-growth guidance of 6.5%-7.5%.
- **2026-05** — Received CE Mark for Libre Duo, a dual glucose-ketone biowearable sensor.
- **2026-04** — Completed enrollment in the TECTONIC U.S. pivotal trial of an investigational coronary intravascular lithotripsy system.
- **2026-03** — Completed the acquisition of Exact Sciences and created a new Cancer Diagnostics business.
- **2026-03** — Expanded precision-oncology test access through integration with Flatiron Health's OncoEMR platform.
- **2026-01** — Announced a collaboration with AtaCor Medical on a next-generation extravascular implantable defibrillator system.

## Links

- Website: https://www.abbott.com/
- LinkedIn: https://www.linkedin.com/company/abbott-
- Twitter/X: https://twitter.com/AbbottNews
- YouTube: https://www.youtube.com/@Abbott
- Instagram: https://www.instagram.com/abbottglobal/
- Facebook: https://www.facebook.com/Abbott/

---

Profile page: https://yespress.io/abbott
Published by YesPress — https://yespress.io
Last updated: 2026-08-13